Minnesota Senate File 2645: Formulary Committee members with a potential conflict of interest participation in committee communications and discussions authorization provision, public comment process for recommendations to the Formulary Committee development by the commissioner of human services requirement provision, and Minnesota Rare Disease Advisory Council expertise sought by the Formulary Committee requirement provision

Minnesota · 2025-2026 session

Status: In committee

Latest action

Referred to Health and Human Services (2025-03-17)

See how SF 2645 affects you on CapitolKey

Browse more bills · CapitolKey home